PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Thorax0 citationsOpen Access

Incidence and prevalence of obstructive sleep apnoea and narcolepsy in the UK: a population-based descriptive study

View Full Paper
HSHelen StrongmanMSMartina SýkorováYYYi Ting Nikki Yu

Key Points

  • This research aims to estimate the prevalence and incidence of diagnosed obstructive sleep apnoea and narcolepsy in the UK over time while examining demographic variations.
  • Conducted a population-based descriptive study from 2000 to 2019.
  • Estimated prevalence and incidence using primary care records linked to hospital data.
  • Defined diagnoses based on first coded record in health data.
  • Stratified data by demographic factors and estimated annual rates.
  • In 2019, the adult standardised prevalence of diagnosed OSA in England was 1.40%, affecting approximately 622,528 individuals.
  • Standardised narcolepsy prevalence was 0.020%, affecting around 11,307 individuals.
  • Both conditions showed significant variations by age, sex, ethnicity, and geographical factors, such as urban or rural living.

Abstract

Background Obstructive sleep apnoea (OSA) and narcolepsy are estimated to affect approximately 4.8% and 0.047% of the UK population, respectively. We do not know how many people have been diagnosed or how this varies over time and by demographic factors. Methods We, therefore, conducted a historical population-based descriptive study estimating prevalence and incidence of diagnosed OSA and narcolepsy in England from 2000 to 2019 stratified by demographic factors, and compared estimates to Scotland, Wales and Northern Ireland. Data were from Clinical Practice Research Datalink (CPRD) primary care records linked to Hospital Episode Statistics (HES) admissions. The study population included people with ≥90 days follow-up between 1 January 2000 and 31 December 2019, no prior record of primary or central sleep apnoea, and aged ≥18 years (OSA only). Diagnoses were defined using the first coded record for each condition in CPRD or HES data. Annual prevalence was estimated at mid-year and directly age/sex-standardised to the national population. Incidence was estimated by dividing new diagnoses by total person-time at risk. Results In England, 2019 adult standardised diagnosed OSA prevalence was 1.40% (95% CI 1.40% to 1.41%) representing approximately 622 528 people; standardised narcolepsy prevalence was 0.020% (95% CI 0.019% to 0.021%) representing approximately 11 307 people. Despite increases over time, diagnosed incidence and prevalence remained substantially lower than published estimates of symptomatic frequency. Rates varied by age, sex, ethnicity and UK nation for both conditions, and urban–rural living, area-based deprivation and practice size for OSA. Conclusion Our results call for high-quality research to drive initiatives that increase diagnosis rates and address variation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Strongman et al. (2026) studied this question.

synapsesocial.com/papers/698828b90fc35cd7a8848751https://doi.org/10.1136/thorax-2025-223863
Ask AI
Helpful
Bookmark
Share
View Full Paper